GE Healthcare to Market Dharmacon RNAi Products in Japan
Dharmacon said this week that it has signed a deal making GE Healthcare the exclusive distribution agent for its RNAi research products in Japan.
Specific terms of the arrangement were not disclosed.
Benitec Names Cancer as Third Disease Area
Benitec reported in its annual general meeting presentation last week that cancer is the third disease area on which the company will focus its drug-development efforts.